CCR4 is highly expressed in both leukemic CTCL including Sézary syndrome and in MF, both in the very early stages (patch and plaque stages) of the disease and in large cell transformations [7], [8], [10], [11], [12]. Here, CCR4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.